Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Biomarker Targeted Stimulation for Epileptiform Events

NCT: NCT06424977 · NOT_YET_RECRUITING

NCT IDNCT06424977
StatusNOT_YET_RECRUITING
Start Date2026-09-01
Completion2030-02-14

Brief Summary

This is a multicenter, prospective, controlled study designed to evaluate treatment with the BTS System.

Frequently Asked Questions

What is Biomarker Targeted Stimulation for Epileptiform Events?

Biomarker Targeted Stimulation for Epileptiform Events is a clinical trial registered under NCT06424977. Current status: NOT_YET_RECRUITING.

What is the status of NCT06424977?

The current status of NCT06424977 (Biomarker Targeted Stimulation for Epileptiform Events) is: NOT_YET_RECRUITING.

When did Biomarker Targeted Stimulation for Epileptiform Events start?

Biomarker Targeted Stimulation for Epileptiform Events started on 2026-09-01.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑